| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3K | -97.6% |
| Cost of Revenue | $3K | -99.5% |
| Gross Profit | $268 | +100.1% |
| R&D Expense | $3.2M | -70.7% |
| SG&A Expense | $16.0M | -1.9% |
| Operating Income | -$19.6M | +29.8% |
| Pre-tax Income | -$42.8M | -22.2% |
| Net Income | -$43.1M | -6.8% |
| EPS (Basic) | -$1153.83 | +62.3% |
| EPS (Diluted) | -$1153.83 | +62.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $43K | +0.0% |
| Inventory | $6K | -48.7% |
| Current Assets | $3.8M | +91.1% |
| Total Assets | $16.5M | -48.6% |
| Current Liabilities | $12.2M | -47.8% |
| Total Liabilities | $12.6M | -47.3% |
| Stockholders' Equity | $5.6M | +1029.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.7M | -53.3% |
| Capital Expenditures | $14K | — |
| Investing Cash Flow | -$2.4M | +51.2% |
| Financing Cash Flow | $30.5M | +35.5% |
| Free Cash Flow | -$25.7M | — |